The NPHS1 gene gives kidney filter cells the instructions to make nephrin, a protein that forms part of the barrier that keeps protein in your blood. This gene helps your body hold on to important proteins instead of losing them into urine. If the NPHS1 gene does not work properly, a baby can develop congenital nephrotic syndrome, often starting before birth or in the first months of life, with swelling, poor growth, and protein in the urine. Treatment focuses on protecting nutrition, fluid balance, and kidney health.
What is a gene?
A gene is a section of DNA that carries information cells use to make molecules or manage processes in the body. Some genes give instructions for building proteins, the parts of cells that do much of the work. Others mainly control when certain processes happen, where they happen, and how strongly they are turned on. Together, genes influence how the body develops and works, and they can shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can read more in the LearnHub.
Overview
NPHS1Gene function
What if the gene works
The NPHS1 gene helps build nephrin, a protein in the kidney’s filtering units. It supports the slit diaphragm, a fine filter that keeps protein in the blood while letting waste pass into urine.
Risk
What if the gene does not work
Variants in the NPHS1 gene often cause congenital nephrotic syndrome, with heavy protein loss in urine and swelling from birth or early infancy. Milder or more severe variants can change when symptoms start and how much kidney function is affected.
Treatment
What does that mean for your treatment
No NPHS1-specific treatment or drug choice approach is currently established. The NPHS1 gene is being studied as a marker of podocyte injury (damage to the kidney’s filtering cells) and as a possible future treatment target in kidney disease.
Conditions associated with NPHS1
Gene function
What if the gene works
In the kidneys, the NPHS1 gene helps the body filter blood while keeping needed proteins in circulation. It is especially important in podocytes, the specialized cells that wrap around tiny kidney blood vessels. Understanding how the NPHS1 gene works helps explain how your kidneys filter protein from the blood in a controlled way.
The NPHS1 gene provides instructions for nephrin, a key protein in the thin barrier between podocytes. This barrier acts like a fine sieve, helping water and small waste products pass while keeping larger blood proteins in place.
Inside podocytes, nephrin helps neighboring foot processes connect in an orderly way. These links form the slit diaphragm (a narrow filtering seam) and help the kidney’s filter stay stable during normal blood flow.
The protein made from the NPHS1 gene also helps podocytes send signals that guide their shape and attachment. This supports day to day upkeep of the filtration barrier so the kidney can keep working smoothly.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NPHS1 gene often change the nephrin protein so it is shortened, unstable, or unable to reach the cell surface and form the kidney’s filtration slit properly. This is how variants influence the NPHS1 gene's function at a cellular level. More severe variants may leave little or no working nephrin, while milder variants can allow some residual activity. That difference often shapes whether congenital nephrotic syndrome begins at birth or appears later and how marked it becomes.
How variants are linked to conditions
Pathogenic variants in the NPHS1 gene cause congenital nephrotic syndrome, most often the Finnish type, a kidney condition that usually begins before birth or in the first months of life. In medical genetics, the NPHS1 gene and congenital nephrotic syndrome are closely linked, especially when a baby has very early, marked protein loss in the urine. Some variants in the NPHS1 gene are also associated with steroid resistant nephrotic syndrome.
A variant is not necessarily a diagnosis
Variants in DNA are a routine feature of human biology and are widely found across the population. Most do not directly affect health and are simply part of normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a firm diagnosis, particularly when several genes and environmental influences also play a role. Still, in certain situations, one well described variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NPHS1, risk is mainly determined by genetics: a child is affected when they inherit harmful changes in both copies of the gene, usually one from each carrier parent. Lifestyle does not meaningfully change the chance of having this condition.
Inheritance of NPHS1 variants
Inheritance of NPHS1 gene variants usually follows an autosomal recessive pattern. This means a child typically inherits one variant in the NPHS1 gene from each parent. When both parents carry one variant, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a child who is also a carrier, and a 25% chance of inheriting neither familial variant. Because the NPHS1 gene is on chromosome 19, this pattern affects males and females equally.
What does my NPHS1 result mean for my family?
For NPHS1, family members can sometimes be carriers even if they have no kidney problems. Brothers and sisters may also be affected or be carriers, so the result can matter for siblings and for future pregnancies in the family. Parents of a child with an NPHS1-related condition are usually carriers, and other close relatives may want to learn whether the variant runs in the family.
Genetic information
Genetic testing
How you find out about variants
NPHS1 genetic testing looks for variants in the NPHS1 gene using a blood sample, saliva, or sometimes a cheek swab. A lab reads the DNA code and checks for changes linked to congenital nephrotic syndrome, often as part of a kidney gene panel or broader sequencing test. Results can confirm whether a pathogenic variant is present.
When should I consider getting a genetic test?
Genetic testing for the NPHS1 gene is worth considering when a baby or young child has very early, severe kidney problems, especially heavy protein loss in the urine, swelling, or nephrotic syndrome. It can also help when this condition runs in the family or when parents want to clarify the chance for another child.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition as well as the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body handles certain medicines, so the same treatment may not work the same way for everyone. Some people break down a drug faster or slower, while others are more or less sensitive to its effects. This is common and can affect how much benefit a medicine gives or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies gene-drug patterns to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the NPHS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so questions about medicines, side effects, or kidney-related symptoms are best discussed with your doctor.
History
Throughout history, clinicians in Finland described infants born with heavy protein loss in the urine and swelling, a pattern later known as congenital nephrotic syndrome of the Finnish type. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became part of the Finnish disease heritage because it appeared more often in that population. In 1998, researchers identified the NPHS1 gene, a major step that explained the inherited cause in many affected families. From these first observations, research expanded steadily. The discovery also changed kidney research more broadly by drawing attention to the structures that keep protein in the blood. Today, the history of the NPHS1 gene is closely linked to both rare disease genetics and modern understanding of inherited kidney conditions.